Research News

The Importance of Positive Thinking on your Health

Monday, 27 November 2017

We didn’t write the book on optimism, but we know the guy who did. In Always Looking Up: The Adventures of an Incurable Optimist, Michael J. Fox sets the example for living. “Your happiness grows in direct proportion to your acceptance and in inverse…

Fox Insight

Podcast -Learn more about Fox Insight

Monday, 27 November 2017

Fox Insight is an online clinical study where people with Parkinson’s disease and their loved ones share information that could transform the search for better treatments. Listen to this podcast More than 13,000 people have volunteered for The Michael J….

Parkinson's Therapeutics Conference

Parkinson’s Research Conference Spotlights Field-wide Advances

Monday, 6 November 2017

On October 30, more than 300 leaders in Parkinson’s disease (PD) research and business development gathered in NYC for The Michael J. Fox Foundation’s 11th Annual Parkinson’s Disease Therapeutics Conference. The event featured the latest in Parkinson’s drug development and…

According to a recent survey conducted by The Michael J. Fox Foundation, only half of U.S. adults are aware that reduced sense of smell can be a precursor to brain disease.

Podcast: Sniff Test for Parkinson’s Disease

Sunday, 22 October 2017

Listen to this Podcast Lack of objective tests to diagnose Parkinson’s disease (PD) challenges drug development and patient care. While scientists are looking to pinpoint PD earlier through skin and spinal fluid, there is also promising research on some less…

Parkinson’s Protein Levels Stable over Year in Early Disease

Monday, 16 October 2017

Today researchers from the Parkinson’s Progression Markers Initiative (PPMI) — a landmark study to find measures of Parkinson’s disease sponsored by The Michael J. Fox Foundation (MJFF) — published the first results looking at protein levels in spinal fluid in…

Grand Rapid Challenges in Parkinson's Scientific Event

Grand Challenges in Parkinson’s Disease Scientific Symposium

Tuesday, 3 October 2017

Leading Parkinson’s experts and advocates from around the world have gathered at Van Andel Research Institute (VARI) in Grand Rapids this week for Grand Challenges in Parkinson’s Disease, a scientific event highlighting the latest breakthroughs in Parkinson’s research and treatment. The theme…

17 New Genetic Variants Linked To Parkinson’s Disease

Sunday, 17 September 2017

A little more than 20 years ago, we thought Parkinson’s had no genetic connection. Today scientists have a growing list of genetic variants and mutations linked to the disease. While we’ve learned a lot in two decades, we know there…

Parkinson's research

Gene Therapy to Enhance Levodopa Response Progressing in Clinical Trials

Sunday, 10 September 2017

Voyager Therapeutics today announced positive interim results from an ongoing Phase Ib, open-label trial testing a gene therapy that helps the brain make dopamine from levodopa, the gold standard treatment for Parkinson’s symptoms. After a one-time surgical procedure to deliver therapy directly…

Parkinson's Puzzle

Can you Help us Solve the Parkinson’s Puzzle?

Saturday, 2 September 2017

It is estimated that over 120,000 Australians will be living with Parkinson’s by 2034 and there are currently no treatments available to prevent, slow, halt or reverse the condition. Treatments currently available assist in controlling symptoms but often have very…

Stem Cells in Parkinson's

Stem Cells Safe in Pre-Clinical Parkinson’s Disease Study

Thursday, 31 August 2017

A new stem cell study, published in the journal Nature, builds on the potential for this therapy in Parkinson’s, but it’s still early days and much work remains to be done. A team of researchers demonstrated that human induced pluripotent stem…

New Dyskensia Drug FDA Approved

FDA Approval for New Drug to Treat Levodopa Induced Dyskinesia

Monday, 28 August 2017

Adamas Pharmaceuticals yesterday announced U.S. Food and Drug Administration (FDA) approval of an extended-release formulation of amantadine (GOCOVRI) to treat dyskinesia in Parkinson’s disease (PD). This is the first drug indicated specifically for dyskinesia — uncontrolled, involuntary movements that can develop with…

Dr Richard Gordon research into Parkinson's disease

Under the Microscope: Dr Richard Gordon

Sunday, 20 August 2017

Shake It Up has a clear mission; to find the cure for Parkinson’s. To achieve this we invest in Australia’s leading Parkinson’s research.We are fortunate to have a dedicated family of supporters who so generously donate and/or fundraise enabling us to…

Nic Dzamko - University of Sydney Parkinson's research

Under the microscope: Dr Nicolas Dzamko

Thursday, 10 August 2017

In this week’s Under the Microscope, we feature Dr Nicolas Dzamko. Based at The University of Sydney he is currently working alongside Professor Glenda Halliday on several exciting Parkinson’s research projects. Briefly outline where you commenced your research journey and…